Skip to content
Screener

Evolent Health, Inc. EVH Investing Cash Flow

Investing Cash Flow at other companies

CVS Health logo
CVS HealthCVS
-$1.88B-84.0%
UnitedHealth Group logo
UnitedHealth GroupUNH
-$1.8B-24.7%
TOI
TOITOI
-$1.04M-416%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$747.39M+3,190%
Health Catalyst logo
Health CatalystHCAT
-$9.41M-110%
Elevance Health logo
Elevance HealthELV
-$1.64B-1,694%

Other financials

Income statement

See full
Revenue$652.5M+46.9%
Gross profit$80.8M-19.5%
Operating income-$9.6M-716%
Net income-$28.4M-42.6%
EPS (diluted)-$0.25+43.2%

Balance sheet

See full
Cash & equivalents$115.7M-23.4%
Total debt$970.4M+13.7%
Total equity$383.2M-57.2%
Total assets$2.0B-19.9%

Cash flow

See full
Operating cash flow-$9.3M+69.3%

Valuation

See full
Market cap$446.58M-58.2%
Enterprise value$1.3B-26.5%
P/S0.2×-0.3×

Profitability

See full
Gross margin17.2%+0.9pp
Operating margin-20.4%-22.4pp
Net margin-24.1%-35.8pp
FCF margin-9.7%

Returns & leverage

See full
Return on equity-79%-99.2pp
Debt / equity2.5×+1.6×
Current ratio1.2×+0.2×

Where this comes from

Reported directly by Evolent Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: Evolent Health, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 8:53 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628908-26-000086
Line itemFor the Six Months Ended June 30, 2026For the Six Months Ended June 30, 2025
Return of equity method investments150788
Purchases of investments and contributions to equity method investees(1,000)
Investments in internal-use software and purchases of property and equipment(13,255)(17,365)
Net cash and restricted cash used in investing activities(13,105)(73,624)
Cash Flows (Used In) Provided by Financing Activities
Changes in working capital balances related to claims processing(3,143)(44,754)
Payment of contingent consideration(1,000)
Proceeds from issuance of long-term debt, net of offering costs221,000

Item 1. Financial Statements

FAQ

What is Evolent Health, Inc.'s investing cash flow?
Evolent Health, Inc. (EVH) reported investing cash flow of -$6.7M in Q2 2026.
How has Evolent Health, Inc.'s investing cash flow changed year-over-year?
Evolent Health, Inc.'s investing cash flow increased by 88.9% year-over-year, from -$60.53M to -$6.7M.
What is the long-term trend for Evolent Health, Inc.'s investing cash flow?
Over 2 years (2022 to 2024), Evolent Health, Inc.'s investing cash flow has grown at a -50.7% compound annual growth rate (CAGR), from -$259.12M to -$62.93M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about Evolent Health, Inc.'s investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude